Glucagonoma is a very rare tumor of the islet cells of the pancreas, which release the hormones insulin and glucagon.
Glucagonoma is usually cancerous (malignant). The cancer tends to spread and get worse.
This cancer affects the islet cells of the pancreas. As a result, they produce too much of the hormone glucagon.
The cause is unknown, but genetic factors play a role in some cases. A family history of multiple endocrine neoplasia type I (MEN I) is a risk factor.
Signs include:
Most of the time the cancer has already spread to the liver when it is diagnosed.
Tests may include:
Surgery to remove the tumor is the preferred treatment. The tumor does not respond to chemotherapy.
Approximately 60% of these tumors are cancerous. Spread to the liver is common.
If the tumor is only in the pancreas and surgery to remove it is successful, patients have a 5-year survival rate of 85%.
The cancer can spread to the liver.
Call your health care provider if you notice symptoms of glucagonoma.
Simon P, Spilcke-Liss E, Wallaschofski H. Endocrine tumors of the pancreas. Endocrinol Metabl Clin North Am. 2006;35:431-437.
Disclaimer: The information contained in this website, and its associated websites, is provided as a benefit to the local community, and the Internet community in general; it does not constitute medical advice. We try to provide quality information, but we make no claims, promises or guarantees about the accuracy, completeness, or adequacy of the information contained in or linked to this website and its associated sites. As medical advice must be tailored to the specific circumstances of each patient and healthcare is constantly changing, nothing provided herein should be used as a substitute for the advice of a competent physician. Furthermore, in providing this service, Adventist HealthCare does not condone or support all of the content covered in this site. As an Adventist health care organization, Adventist HealthCare acts in accordance with the ethical and religious directives for Adventist health care services.